Zhejiang CONBA Pharmaceutical Co.,Ltd.

Shanghai Stock Exchange 600572.SS

Zhejiang CONBA Pharmaceutical Co.,Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 1.63

Zhejiang CONBA Pharmaceutical Co.,Ltd. Price to Sales Ratio (P/S) is 1.63 on January 14, 2025, a -12.59% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Zhejiang CONBA Pharmaceutical Co.,Ltd. 52-week high Price to Sales Ratio (P/S) is 2.11 on May 14, 2024, which is 29.49% above the current Price to Sales Ratio (P/S).
Zhejiang CONBA Pharmaceutical Co.,Ltd. 52-week low Price to Sales Ratio (P/S) is 1.51 on September 18, 2024, which is -7.33% below the current Price to Sales Ratio (P/S).
Zhejiang CONBA Pharmaceutical Co.,Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.79.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shanghai Stock Exchange: 600572.SS

Zhejiang CONBA Pharmaceutical Co.,Ltd.

CEO	Mr. Guoliang Luo
IPO Date	April 12, 2004
Location	China
Headquarters	No. 568, Binkang Road
Employees	8,411
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of traditional Chinese medicines and botanical products in China. It offers chemical medicines, Chinese patent medicines, eye health products, nutritional supplements, health supplies, healthy daily necessities and food products, and other personal care products. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd.

Key trends

Past 5 years